Atropos Health, based in Palo Alto, California, has unveiled new AI tools for monitoring patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disorder. These tools aim to provide personalized real-world evidence and insights by analyzing real-world clinical data. The company had previously announced an algorithm to enhance early diagnosis for PNH. This recent development introduces progression monitoring tools to further aid in managing the condition. Atropos Health continues to innovate in the realm of medical technology to improve patient care.